Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-01

Clinical Trial Update: Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome [Phase 2]

View source ↗

Summary

A Phase II trial evaluating DA-6034 eye drops for Dry Eye Syndrome has completed, sponsored by Dong-A ST Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DA-6034 Eye Drops (DA-6034)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED